Advertisement

Journal of Genetic Counseling

, Volume 25, Issue 3, pp 413–421 | Cite as

The Quality of Genetic Counseling and Connected Factors as Evaluated by Male BRCA1/2 Mutation Carriers in Finland

  • Outi Kajula
  • Maria Kääriäinen
  • Jukka S. Moilanen
  • Helvi Kyngäs
Original Research

Abstract

There is little written about the quality of genetic counseling for men with the BRCA1/2 mutation. The purpose of this study was to describe the quality of genetic counseling and connected factors according to Finnish male BRCA1/2 mutation carriers’ (n = 35) perspectives and reasons for seeking genetic counseling. Data were collected from the Departments of Clinical Genetics at five Finnish university hospitals. The exploratory study design was conducted using a 51-item questionnaire based on a previously devised quality of counseling model and analyzed using non-parametric tests and principle content analysis. The satisfaction level with genetic counseling was high, especially with regard to the content of genetic counseling. The benefit of genetic counseling on the quality of life differed significantly (p < 0.001–0.009) from other factors. In particular, genetic counseling was in some cases associated to reduce the quality of life. Only 49 % of the male carriers felt they received sufficient counseling on social support. Attention to individual psychosocial support was proposed as an improvement to genetic counseling. Primary and secondary reasons for seeking genetic counseling and background information, such as education, affected the perceived quality of genetic counseling. The results of the study could be used to tailor genetic counseling for male BRCA1/2 mutation carriers.

Keywords

BRCA1 BRCA2 Male carriers Genetic counseling Quality 

Notes

Acknowledgments

The authors would like to thank Drs Kristiina Aittomäki, Jaakko Ignatius, Tarja Mononen, Kalle Simola and the assistants at the Departments of Clinical Genetics at the participating university hospitals for helpful discussions and data collection. We thank genetic nurses at the Departments of Clinical Genetics for sharing their expertise in the instrument developing process. M.Sc. Helena Laukkala is thanked for statistical analysis guidance. We also thank all male carriers who participated in this study. This study was partly supported by the Department of Clinical Genetics at Oulu University Hospital (Genetic Diseases in Northern Finland research group).

Conflict of Interest

Outi Kajula, Maria Kääriäinen, Jukka S. Moilanen and Helvi Kyngäs declare that they have no conflict of interest.

Human Studies and Informed Consent

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. Informed consent was obtained from all patients for being included in the study.

Animal Studies

No Animal studies were carried out by the authors for this article.

References

  1. Bjorvatn, C., Eide, G. E., Hanestad, B. R., Øyen, N., Havik, O. E., Carlsson, A., et al. (2007). Risk perception, worry and satisfaction related to genetic counseling for hereditary cancer. Journal of Genetic Counseling, 16(2), 211–222.CrossRefPubMedGoogle Scholar
  2. Braithwaite, D., Emery, J., Walter, F., Prevost, T., & Sutton, S. (2006). Psychological impact of genetic counseling for familial cancer: systematic review and meta-analysis. Familial Cancer, 5, 61–75.CrossRefPubMedGoogle Scholar
  3. Daly, P. A., Nolan, C., Green, A., Ormiston, W., Cody, N., McDevitt, T., et al. (2003). Predictive testing for BRCA1 and BRCA2 mutations: a male contribution. Annals of Oncology, 14(4), 549–553.CrossRefPubMedGoogle Scholar
  4. EuroGentest (2008). Recommendations for genetic counselling related to genetic testing. http://www.eurogentest.org/index.php?id=674. Accessed 26 January 2014.
  5. Fantini-Hauwel, C., Dauvier, B., Arciszewski, T., Antoine, P., & Manouvrier, S. (2011). Genetic testing for hereditary cancer: effects of alexithymia and coping strategies on variations in anxiety before and after result disclosure. Psychology and Health, 26(7), 855–873.CrossRefPubMedGoogle Scholar
  6. Hallowell, N., Ardern-Jones, A., Eeles, R., Foster, C., Lucassen, A., Moynihan, C., et al. (2005). Men’s decision-making about predictive BRCA1/2 testing: the role of family. Journal of Genetic Counseling, 14(3), 207–217.CrossRefPubMedGoogle Scholar
  7. Hallowell, N., Arden-Jones, A., Eeles, R., Foster, C., Lucassen, A., Moynihan, C., et al. (2006). Guilt, blame and responsibility: men’s understanding of their role in the transmission of BRCA1/2 mutations within their family. Sociology of Health & Illness, 28(7), 969–988.CrossRefGoogle Scholar
  8. Kaakinen, P., Kääriäinen, M., & Kyngäs, H. (2012a). The chronically ill patients’ quality of counselling in the hospital. Journal of Nursing Education and Practice, 2(4), 114–123.CrossRefGoogle Scholar
  9. Kaakinen, P., Patala-Pudas, L., Kyngäs, H., & Kääriäinen, M. (2012b). Counseling chronically ill adults in the healthcare setting: an integrative literature review. Journal of Nursing Education and Practice, 2(3), 185–202.CrossRefGoogle Scholar
  10. Kaakinen, P., Kyngäs, H., & Kääriäinen, M. (2013). Predictors of good-quality counselling from the perspective of hospitalised chronically ill adults. Journal of Clinical Nursing, 22(19–20), 2704–2713.CrossRefPubMedGoogle Scholar
  11. Kääriäinen, M. (2007). Quality of counselling: The development of a hypothetical model (Finnish). Doctoral Dissertation. Acta Universitas Ouluensis D937. Oulu University Press, Oulu.Google Scholar
  12. Kääriäinen, M., & Kyngäs, H. (2010). The quality of patient education evaluated by the health personnel. Scandinavian Journal of Caring Science, 24(3), 548–556.CrossRefGoogle Scholar
  13. Kääriäinen, M., Kukkurainen, M. L., Kyngäs, H., & Karppinen, L. (2011). Improving the quality of rheumatoid arthritis patients’ education using written information. Musculoskeletal Care, 9(1), 19–24.CrossRefPubMedGoogle Scholar
  14. Kyngäs, H., Kukkurainen, M. L., & Mäkeläinen, P. (2005). Patients’ education from the perspective of health care providers (Finnish). Tutkiva hoitotyö, 3(2), 12–17.Google Scholar
  15. Levy-Lahad, E., & Friedman, E. (2007). Cancer risks among BRCA1 and BRCA2 mutation carriers. British Journal of Cancer, 96(1), 11–15.CrossRefPubMedPubMedCentralGoogle Scholar
  16. Liede, A., Metcalfe, K., Hanna, D., Hoodfar, E., Snyder, C., Durham, C., et al. (2000). Evaluation of the needs of male carriers of mutations in BRCA1 and BRCA2 who have undergone genetic counseling. American Journal of Human Genetics, 67(6), 1494–1504.CrossRefPubMedPubMedCentralGoogle Scholar
  17. Lipponen, K., Kyngäs, H., & Kääriäinen, M. (2006). Surgical nurses readiness for patient counselling. Journal of Orthopaedic Nursing, 10, 221–227.CrossRefGoogle Scholar
  18. Lobb, E. A., Butow, P. N., Meiser, B., Barratt, A., Gaff, C., Young, M. A., et al. (2002). Tailoring communication in consultations with women from high risk breast cancer families. British Journal of Cancer, 87, 502–508.CrossRefPubMedPubMedCentralGoogle Scholar
  19. Lodder, L., Frets, P. G., Trijsburg, R. W., Tibben, A., Meijers-Heijboer, E. J., Duivenvoorden, H. J., et al. (2001). Men at risk of being a mutation for hereditary breast /ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing. European Journal of Human Genetics, 9(7), 492–500.CrossRefPubMedGoogle Scholar
  20. Mendes, A. F., Santos, T. A., & Sousa, L. (2011). Experiencing genetic counselling for hereditary cancers: the client’s perspective. European Journal of Cancer Care, 20, 204–211.CrossRefPubMedGoogle Scholar
  21. Miki, Y., Swenson, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., et al. (1994). A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science, 266(5182), 66–71.CrossRefPubMedGoogle Scholar
  22. Petrucelli, N., Daly, M. B., & Feldman, G. L. (1998). BRCA1 and BRCA2 hereditary breast and ovarian cancer. NCBI Bookshelf, National Institutes of Health. http://www.ncbi.nlm.nih.gov/books/NBK1247/ Updated 26 September 2013. Accessed 21 January 2014.
  23. Polit, D. F., & Beck, C. T. (2006). The content validity index: are you sure you know what’s being reported? Critique and recommendations. Research in Nursing & Health, 29, 489–497.CrossRefGoogle Scholar
  24. Resta, R., Biesecker, B. B., Bennett, R. L., Blum, S., Hahn, S. E., Strecker, M. N., et al. (2006). A new definition of genetic counseling: national society of genetic counselors’ task force report. Journal of Genetic Counseling, 15(2), 77–83.CrossRefPubMedGoogle Scholar
  25. Shiloh, S., Dagan, E., Friedman, I., Blank, N., & Friedman, E. (2013). A follow-up study on men tested for BRCA/BRCA2 mutations: impacts and coping process. Psycho-Oncology, 22, 417–425.PubMedGoogle Scholar
  26. Strømsvik, N., Råheim, M., Øyen, N., & Gjengedal, E. (2009). Men in the women’s world of hereditary breast cancer – a systematic review. Familial Cancer, 8(3), 221–229.CrossRefPubMedGoogle Scholar
  27. Strømsvik, N., Råheim, M., Øyen, N., Engebretsen, L. F., & Gjengedal, E. (2010). Stigmatization and male identity: Norwegian males experience after identification as BRCA1/2 mutation carriers. Journal of Genetic Counseling, 19(4), 360–370.CrossRefPubMedGoogle Scholar
  28. Strømsvik, N., Råheim, M., & Gjengedal, E. (2011). Cancer worry among Norwegian male BRCA1/2 mutation carriers. Familial Cancer, 10, 597–603.CrossRefPubMedPubMedCentralGoogle Scholar
  29. Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., et al. (1995). Identification of the breast cancer susceptibility gene BRCA2. Nature, 378(6559), 789–792.CrossRefPubMedGoogle Scholar

Copyright information

© National Society of Genetic Counselors, Inc. 2015

Authors and Affiliations

  • Outi Kajula
    • 1
    • 2
    • 3
  • Maria Kääriäinen
    • 1
    • 2
  • Jukka S. Moilanen
    • 2
    • 3
  • Helvi Kyngäs
    • 1
    • 2
    • 4
  1. 1.Research Unit of Nursing Science and Health ManagementUniversity of OuluOuluFinland
  2. 2.Medical Research CenterOulu University Hospital and University of OuluOuluFinland
  3. 3.Department of Clinical GeneticsOulu University HospitalOuluFinland
  4. 4.Northern Ostrobothnia Hospital DistrictOuluFinland

Personalised recommendations